Valproic Acid

Overview

Valproic Acid—also known as Valproate, Sodium Valproate, Divalproex Sodium, VPA, and Valproate Semisodium—is a widely used anticonvulsant and mood stabilizer. It enhances the activity of GABA (gamma-aminobutyric acid), the primary inhibitory neurotransmitter in the brain. By increasing GABA levels, it regulates neuronal excitability, stabilizes electrical activity, and reduces the likelihood of seizures.

Apart from its antiepileptic properties, Valproic Acid also exhibits neuroprotective effects, thanks to its antioxidant and anti-inflammatory actions. Clinically, it is prescribed for:

1. Generalized and partial seizures (epilepsy)
2. Bipolar disorders, especially manic episodes and mood stabilization
3. Migraine prevention, where it reduces the frequency and severity of attacks

However, Valproic Acid carries significant risks, particularly liver toxicity, pancreatitis, hyperammonemia, and metabolic disturbances. Therefore, drug level monitoring is crucial for patient safety, especially during prolonged therapy or high-dose treatment.

Laboratory measurement of Valproic Acid levels is essential and must be done using appropriate sample handling. Blood should be collected before the daily dose, using plain red-capped tubes or EDTA tubes—never gel tubes, as gels absorb Valproic Acid and produce false-low results.

The therapeutic range is 50–100 mcg/mL, while toxicity occurs above 100 mcg/mL, and inadequate dosage shows levels below 50 mcg/mL.

Symptoms

Symptoms associated with Valproic Acid can arise from side effects, toxicity, or related metabolic disturbances.

Common Symptoms and Adverse Effects:

1. CNS: Tremors, sedation, agitation, verbal abnormalities, seizures (in toxicity), hallucinations, aggression
2. Gastrointestinal: Nausea, vomiting, indigestion, abdominal cramps, diarrhea, anorexia, weight loss, hypersalivation
3. Hepatic: Elevated liver enzymes, hepatotoxicity, or liver failure
4. Pancreatic: Nausea, vomiting, abdominal pain due to pancreatitis
5. Metabolic: Raised ammonia levels leading to lethargy, confusion, vomiting, or encephalopathy
6. Musculoskeletal & Bone Health: Osteoporosis and increased fracture risk
7. Hematological: Prolonged bleeding time, leukopenia, thrombocytopenia, anemia, bone marrow depression
8. Dermatological: Skin rashes, hair loss
9. Reproductive: Irregular menstrual bleeding, amenorrhea

Severe Overdose Symptoms:

1. Deep coma
2. Pulmonary edema
3. Multi-organ dysfunction
4. Possible death

Symptoms occur more frequently when drug levels exceed the safe therapeutic range or when the drug is used long-term without medical monitoring.

Causes

The causes of Valproic Acid toxicity or adverse reactions relate primarily to dosage, organ function, and underlying metabolic vulnerabilities.

Key Causes Include:

1. Prolonged use of Valproic Acid
2. High doses leading to accumulation and toxicity
3. Liver impairment, decreasing the body’s ability to metabolize the drug
4. Pancreatic inflammation
5. Urea cycle disorders, which predispose to hyperammonemia
6. Drug interactions affecting metabolism
7. Renal impairment reducing drug clearance
8. Mitochondrial dysfunction, which increases sensitivity to toxicity

False-positive results in the Valproic Acid blood test may occur in conditions such as ketonuria, elevated AST/ALT/LDH/ALP, prolonged bleeding, or abnormal thyroid function tests.

Improper timing of blood sample collection—especially after a dose—is a significant cause of inaccurate results.

Risk Factors

Individuals with certain medical conditions or genetic predispositions are at higher risk of developing Valproic Acid-related complications.

Major Risk Factors Include:

1. Pregnancy & lactation: High risk of teratogenicity, especially neural tube defects
2. Bleeding disorders and coagulation abnormalities
3. Hepatic impairment or active liver disease
4. Pancreatitis or history of pancreatitis
5. Hypersensitivity to Valproic Acid
6. Mitochondrial disorders
7. Urea cycle disorders, which may trigger severe hyperammonemia
8. Children under 2 years with viral infections
9. Severe renal impairment or chronic renal failure
10. Obesity and metabolic syndrome, due to insulin resistance risk

These risk factors increase the likelihood of toxicity, organ damage, or adverse reactions.

Prevention

Preventing Valproic Acid-related complications requires careful monitoring, correct dosing, and proper laboratory handling.

Testing & Laboratory Prevention:

1. No special preparation is required, but collect blood before the daily dose.
2. Collect 3–5 mL blood in plain red-capped or EDTA tubes—avoid gel tubes.
3. Separate serum immediately after clot formation.
4. Use spectrophotometry for accurate measurement.

Clinical Prevention Measures:

1. Regular monitoring of liver function tests, BUN, creatinine, serum potassium, and CBC.
2. Stop Valproic Acid immediately if pregnancy is suspected or confirmed.
3. Use folic acid supplementation to reduce neural tube defects.
4. Monitor for signs of hepatic or pancreatic dysfunction.
5. Avoid unnecessary dose changes, which can trigger seizures or side effects.